Live feed
Filing
SC 13G/A
SC 13G/A0001453938-14-000004·Prosight Fund, LP
Schedule 13G ownership disclosure
Transcept Pharmaceuticals Inc
Security class unavailable · CUSIP: 89354M106
Event date: 2014-08-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,071,429
- Percent of class
- 5.5900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001453938-14-000004
- Form type
- SC 13G/A
- Filer
- Prosight Fund, LP
- CIK
- CIK 1453938
- Filed
- Aug 26, 2014
- Reporting period
- Aug 15, 2014
- Description
- Schedule 13G beneficial ownership